The following text was automatically extracted from the image on this page using optical character recognition software:
Texas Preventable Disease News, week no. 33 Page 2
REFERENCES:
1. Reingold AL, Dan BB, Shands KN, et al. Toxic-shock syndrome not associated with
menstruation: a review of 54 cases. Lancet 1982; 1-4.
2. Reingold AL, Hargrett NT, Dan BB, et al. Nonmenstrual toxic shock syndrome:
review of 130 cases. Annals of Internal Medicine 1982; 96 (Part 2):871-874.
a
3. Osterholm MT, Davis JP, Gibson RW, et al. Tri-state toxic-shock syndrome study:
I. Epidemiologic findings. J Infect Dis 1982; 145:431-440.
4. Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating
women: association with tampon use and Staphylococcus aureus and clinical
features in 52 cases. N Engl J Med 1980; 303:1436-1442.
Figure 1. Cases of TSS Reported in Texas
by Date of Onset, 1978-1983
D
TAMPON-RELATED
E NON-TAMPON RELATED
1978 - 1 CASE
1979 - 4 rASES
1980 - 14 ADDITIONAL CASES
(FIRST 7 MONTHS)
aX
w
F
FTI rl_
61 1 1 L-0
A S 0 N D J F M A M J J A S 0 N D J F M A M J J A S 0 N D J F M A M J
1980 1981
1982
1983
RABIES BOOSTER IMMUNIZATIONS WITH HDCV
MAINTAINING PRE-EXPOSURE STATUS: Persons with a continuing risk of exposure to
rabies should receive a one-milliliter dose of Human Diploid Cell Vaccine (HDCV)
every two years after the basic pre-exposure series.
IF PREVIOUSLY IMMUNIZED PERSON IS EXPOSED TO RABIES: Persons who have been
previously immunized with HDCV (either pre-exposure or post-exposure series) should
be given two doses of HDCV, one immediately and one three days later. Rabies Immune
Globulin (RIG) should not be given. If the person's last immunization was not with
HDCV, then use the two-dose booster schedule only if an adequate antibody titer was
demonstrated at that time. Otherwise, a single dose of RIG and the regular five-dose
series of HDCV should be given.
SEROLOGIC TESTING: Routine serologic testing for rabies antibody is no longer
recommended except when an immune deficiency exists in the person receiving HDCV. In
such cases, sera should be submitted through the Bureau of Laboratories, Texas
Department of Health, to the Centers for Disease Control. Specimens must be
accompanied by documentation regarding the immune deficiency.
AIDS CASES IN TEXAS BY YEAR OF DIAGNOSIS
1980 1981 1982 1983
1 5 19 32
w
a
J
J
w
N
W
Vi
Q
U